Near Infrared Spectroscopy (NIRS) Market Size to Reach USD 962.7 million in 2032

(MENAFN- Navistrat Analytics) September 02, 2025- The expanding application of near-infrared spectroscopy (NIRS) in pharmaceuticals and healthcare is a key factor driving revenue growth in the market. NIRS is a noninvasive technique used to measure tissue oxygen saturation in organs such as the brain, kidneys, and gut. By analyzing changes in the attenuation of near-infrared light passing through the brain, it provides measurements of cerebral regional oxygen saturation (CrSO₂). In neonatal intensive care units (NICUs), NIRS has become increasingly valuable for monitoring extremely preterm infants and neonates with conditions such as encephalopathy, congenital heart disease (CHD), anemia, respiratory distress, and brain injury.

In September 2024, SpectraWAVE, Inc.—a medical imaging company dedicated to enhancing treatment and outcomes for patients with coronary artery disease (CAD)—secured a USD 50 million Series B funding round. The investment was led by Johnson & Johnson Innovation – JJDC, Inc., with participation from S3 Ventures, Lumira Ventures, SV Health Investors, Deerfield Management, NovaVenture, and Heartwork Capital, underscoring investor confidence in NIRS-related innovations.

Beyond healthcare, rapid, and accurate analysis is becoming increasingly critical for quality assurance, authenticity testing, and food safety in the evolving food industry landscape. Near-infrared spectroscopy has gained strong traction as a non-destructive, fast, and environmentally friendly analytical tool due to its versatility. However, its widespread integration into regulatory frameworks remains limited, with only 25 internationally recognized analytical method documents currently endorsing its application.

Segments market overview and growth Insights
Based on product type, the Near Infrared Spectroscopy (NIRS) market is segmented into benchtop NIRS systems and portable/handheld NIRS systems. The leukemia segment accounted for the largest market share in 2024. The benchtop NIRS systems segment accounted for the largest market share in 2024. Benchtop near-infrared spectrometers are stationary instruments designed to deliver high-performance analysis in controlled laboratory environments. Offering superior resolution, sensitivity, and versatility, these systems are well-suited for the detailed examination of solids, liquids, and powders. Their widespread use in research, quality control, and method development has further strengthened their dominance in the market.

Regional market overview and growth insights
Europe held the largest market share in the Near Infrared Spectroscopy (NIRS) market in 2024. The market is being driven by non-destructive, rapid, and cost-effective analysis, expanding use in pharmaceuticals and healthcare, and growing adoption in environmental monitoring. Near-infrared spectroscopy plays a vital role in the synthesis and purification of active pharmaceutical ingredients (APIs) as well as in monitoring biopharmaceutical fermentation processes. The technique is particularly well-suited for analyzing complex mixtures, making it highly valuable in pharmaceutical applications. Its ability to deliver rapid results allows for real-time assessment of fast chemical reactions during API production. Additionally, NIRS offers strong computational capabilities, enabling the simultaneous monitoring of multiple components in a bioprocess, often tracking a dozen nutrients and by-products at once.

Competitive Landscape and Key Competitors
The Near Infrared Spectroscopy (NIRS) market is characterized by a fragmented structure, with many competitors holding a significant share of the market. list of major players included in the Near Infrared Spectroscopy (NIRS) market report are:

o Bruker Corporation
o Malvern Panalytical Ltd
o Thermo Fisher Scientific Inc.
o Metrohm AG
o VIAVI Solutions Inc.
o PerkinElmer
o Agilent Technologies Inc.
o trinamiX
o InnoSpectra Corporation
o Oxford Instruments
o BÜCHI Labortechnik AG
o Carl Zeiss AG
o Lumex Instruments
o JASCO Global
o Hamamatsu Photonics K.K.

Major strategic developments by leading competitors
Bruker Corporation: In February 2025, Bruker Corporation introduced the VERTEX NEO Platform, debuting its first product, the VERTEX NEO R. This new release continues the legacy of high-end Fourier-Transform Infrared (FTIR) instrumentation, delivering exceptional, disturbance-free performance for both academic and industrial research and development. Positioned as the successor to the VERTEX 70v, the VERTEX NEO R integrates significant advancements in FTIR research technology, enhanced by Bruker’s proven MultiTect detector system.

trinamiX GmbH: In June 2023, trinamiX GmbH, a prominent provider of mobile spectroscopic solutions, launched its next-generation handheld NIR spectrometer. The new device integrates the company’s latest scientific advancements with valuable insights gathered from industry experts, customers, and partners. Branded as trinamiX PAL Two, the spectrometer is designed to be future-ready, emphasizing three core principles: adaptability, durability, and user-friendliness.

Navistrat Analytics has segmented the Near Infrared Spectroscopy (NIRS) market based on product type, technology, application, and end-use, and region:
• Product Type Outlook (Revenue, USD Million; 2022-2032)
o Benchtop NIRS Systems
o Portable/Handheld NIRS Systems

• Technology Outlook (Revenue, USD Million; 2022-2032)
o Micro-NIR Technology
o FT-NIR (Fourier Transform NIR)
o Dispersive NIR
o Acousto-Optic Tunable Filter (AOTF)-based NIRS
o Others

• Application Outlook (Revenue, USD Million; 2022-2032)
o Medical & Clinical Diagnostics
o Pharmaceutical & Biotechnology
o Food & Beverage Industry
o Agriculture
o Chemical Industry
o Environmental Science
o Others

• End-Use Outlook (Revenue, USD Million; 2022-2032)
o Hospitals & Clinics
o Pharmaceutical & Biotechnology
o Food Processing Units & Manufacturers
o Agricultural Institutions
o Contract Research Organizations (CROs)
o Research & Academic Institutes

• Regional Outlook (Revenue, USD Million; 2022-2032)
o North America
a. U.S.
b. Canada
c. Mexico
o Europe
a. Germany
b. France
c. U.K.
d. Italy
e. Spain
f. Benelux
g. Nordic Countries
h. Rest of Europe
o Asia Pacific
a. China
b. India
c. Japan
d. South Korea
e. Oceania
f. ASEAN Countries
g. Rest of APAC
o Latin America
a. Brazil
b. Rest of LATAM
o Middle East & Africa
a. GCC Countries
b. South Africa
c. Israel
d. Turkey
e. Rest of MEA

@Navistrat Analytics

MENAFN02092025008152017457ID1110003849